Author details

Full Name

Tomasz Dylag

Affiliation

ORCID

Career Start Year

2003

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
30174434	The European Innovative Medicines Initiative: Progress to Date.	Pharmaceut Med	2018
22519700	Implementation of proteomic biomarkers: making it work.	Eur J Clin Invest	2012
20951846	"4D Biology for health and disease" workshop report.	N Biotechnol	2011
21179890	Basic and clinical proteomics from the EU Health Research perspective.	Proteomics - Clinical Applications	2010
19344107	Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles.	J Proteome Res	2009
18706462	Cryptic peptide derived from the rat neuropeptide FF precursor affects G-proteins linked to opioid receptors in the rat brain.	Peptides	2008
17980934	A novel cryptic peptide derived from the rat neuropeptide FF precursor reverses antinociception and conditioned place preference induced by morphine.	Peptides	2008
17107711	The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol.	Neuropeptides	2007
17884254	Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.	Peptides	2007
17113834	Methods for samples preparation in proteomic research.	Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences	2007
16581157	Rat brain proteome in morphine dependence.	Neurochemistry International	2006
16964434	Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine.	International Journal of Molecular Medicine	2006
16730858	The activity of CART peptide fragments.	Peptides	2006
17088012	CART (85-102)-inhibition of psychostimulant-induced hyperlocomotion: importance of cyclization.	Peptides	2006
15767845	Is the nociceptin (NOP) receptor involved in attenuation of the expression of sensitization to morphine-induced hyperlocomotion in mice?	Behavioural Pharmacology	2005
15464192	Influence of nociceptin(1-17) fragments and its tyrosine-substituted derivative on morphine-withdrawal signs in rats.	Neuropeptides	2004
15255187	Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family.	Biological Chemistry	2004
15571863	Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.	European Journal of Medicinal Chemistry	2004
12657894	Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence.	NeuroReport	2003
14515158	Desorption/ionization on silicon for small molecules:a promising alternative to MALDI TOF.	Acta Biochimica Polonica	2003
12921868	Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats.	European Journal of Pharmacology	2003